x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:04:12

Legend Biotech CEO Ying Huang shares a post-earnings...

BiotechTV - News ·

2025/11/13

He describes how Legend is no longer capacity constrained for it's CAR-T treatment, Carvykti, and previews the upcoming ASH conference.

en-us

00:12:26

Apogee will have at lest four key trial readouts for...

BiotechTV - News ·

2025/11/12

CEO Michael Henderson walks us through what will be a busy year for the company.

en-us

00:05:11

Avalo Therapeutics is developing a high affinity...

BiotechTV - News ·

2025/11/12

CEO Garry Neil describes the target and how he believes Avalo's therapy has especially high affinity. Approximately 1% of the population is believe to have HS.

en-us

00:05:58

Stifel's Head of Global Equity Capital Markets Seth...

BiotechTV - News ·

2025/11/12

He says that investors are placing fewer, but larger bets on companies lately, and he expects a 'healthy' IPO market in 2026.

en-us

00:08:36

Sionna Therapeutics is trying to improve the...

BiotechTV - News ·

2025/11/12

CEO Mike Cloonan describes the unmet need for better treatments that exists today in CF, and discusses Sionna's development plans.

en-us

00:12:21

Stifel's I&I expert Alex Thompson shares his take on...

BiotechTV - News ·

2025/11/12

He comments on Kymera, Apogee, Avalo, Veridian, Moonlake, Spyre, and Oruka.

en-us

00:09:22

Celcuity release what it believes is practice...

BiotechTV - News ·

2025/11/11

He discusses the pathway and gedatolisib's ability to cover it holistically. Plus, future plans for filing and additional data in breast cancer and beyond.

en-us

00:06:31

Spyre Therapeutics is developing a basket of...

BiotechTV - News ·

2025/11/11

CEO Cameron Turtle describes the improvements Spyre is making in its therapies. 2026 is going to be a data rich year for IBD.

en-us

00:06:49

Vicore Pharma is leveraging in understanding the...

BiotechTV - News ·

2025/11/11

CEO Ahmed Mousa walks us through the sciences and describes how data stacked up against a synthetic external control that was presented at a medical meeting this summer.

en-us

00:09:37

The early part of 2026 is going to be a key time for...

BiotechTV - News ·

2025/11/11

CEO Curran Simpson describes REGENXBIO's expertise in AAV, and walks us through the company's programs.

en-us

00:08:46

Aardvark Therapeutics' approach to obesity is to...

BiotechTV - News ·

2025/11/11

Founder and CEO Tien Lee describes how Aardvark's approach focuses on the gut-brain axis.

en-us

00:13:15

Stifel's Head of Therapeutics Paul Matteis shares his...

BiotechTV - News ·

2025/11/11

He shares his thoughts on uniQure, Xenon, Alkermes, Compass Pathways, GH Research MindMed, and Dyne.

en-us

00:07:47

Upstream Bio is focused on the TSLP space, and has a...

BiotechTV - News ·

2025/11/11

CEO Rand Sutherland describes TSLP pathway and Upstream's choice to hit the receptor, and how this could define the company's competitive profile.

en-us

00:10:31

Adaptyx announced $14M in additional seed financing...

BiotechTV - News ·

2025/11/10

Co-Founder & CEO Vijit Sabnis describes the company's goal of taking the field from continuous glucose monitoring to capturing a wider range of human biochemistry, and the clinical benefits that could flow from that.

en-us

00:09:41

Aulos Bioscience presented phase 2 data at SITC for...

BiotechTV - News ·

2025/11/08

CEO Aron Knickerbocker walks us through the data and describes why he believes imneskibart's ability to show a higher Teff/Treg ratio in patients, and how it correlates with longer time on treatment and overall survival, may be unique in the IL-2 class.

en-us

00:08:34

Enara Bio publicly announced its first cancer...

BiotechTV - News ·

2025/11/08

CEO Kevin Pojasek describes the past challenge of drugging FOXM1, and why he believes DARKFOX will be an ideal target for the company's T-cell engager platform.

en-us

00:11:53

Compugen is standing firm on its belief that TIGIT...

BiotechTV - News ·

2025/11/08

The company's new CEO Eran Ophir discusses the computational work that when into Compugen's understanding of TIGIT biology, and he walks us through their partnership with AstraZeneca. Plus, recent ESMO data for PVRIG and a trial in progress for IL18BP.

en-us

00:12:56

Synthekine presented data at SITC on its α/β-IL-2...

BiotechTV - News ·

2025/11/08

Co-Founder & CEO Debanjan Ray walks us through learnigs the IL-2 space has seen over the years, and describes why Synthekine is targeting both the α and β receptors in this case. In addition to the phase 1a/1b that is reading at SITC, Synthekine has already started a randomized phase 2 study.

en-us

00:09:18

Marengo Therapeutics has presented data at ESMO and...

BiotechTV - News ·

2025/11/08

CEO Zhen Su walks us through the data, which had 46 efficacy-evaluable patients and showed a 20% ORR and 80% DCR across multiple tumor types.

en-us

00:08:01

Brain shuttle technologies have been in the news a...

BiotechTV - News ·

2025/11/08

She and her colleagues at inThought Research recently published a report summarizing the brain shuttle technology research landscape in the biotech sector.

en-us

342 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter